Issues in anticoagulant therapy: Recent trials start to answer the tough questions
Amir K. Jaffer, MD
Medical Director, the IMPACT Center and The Anticoagulation Clinic, Section of Hospital Medicine, Department of General Internal Medicine, The Cleveland Clinic Foundation
Address: Amir K. Jaffer, MD, Department of General Internal Medicine, A72, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail email@example.com
The author has indicated that he has received grant or research suport from the Astra Zeneca corporation, serves as a consultant for the Sanofi-Aventis corporation, and is on the speaker’s bureau of the Sanofi-Aventis corporation.
This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.
Medical Grand Rounds articles are based on edited transcripts from presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.
ABSTRACTRecent trials provide evidence to help guide the management of patients with recurrent episodes of venous thromboembolism, cancer patients with venous thromboembolism, and patients receiving anticoagulant therapy who must undergo surgery.